NCT02709616 - Personalized Cellular Vaccine for Glioblastoma (PERCELLVAC) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 1, 2016

Primary Completion Date

October 31, 2017

Study Completion Date

June 30, 2019

Conditions

Glioblastoma

Interventions

BIOLOGICAL

Personalized cellular vaccine

Biological: DC-based cellular vaccine. Subjects will undergo surgical resection and standard 6-week chemo/radiotherapy and cycles of TMZ treatment. They will receive biweekly cellular vaccines.

Trial Locations (1)

Unknown

Guangdong 999 Brain Hospital, Guangzhou